Pathology of Early Hepatocellular Carcinoma: Conventional and Molecular Diagnosis

被引:106
|
作者
Roskams, Tania [1 ]
Kojiro, Masamichi [2 ]
机构
[1] Univ Louvain, Dept Morphol & Mol Pathol, B-3000 Louvain, Belgium
[2] Kurume Univ, Kurume, Fukuoka 830, Japan
关键词
Hepatocellular carcinoma; stromal invasion; dysplastic nodule; glypican-3; heat shock protein 70; glutamine synthetase; nodule-in-nodule; AMMONIA-METABOLIZING ENZYMES; CIRRHOTIC LIVER EXPLANTS; GRADE DYSPLASTIC NODULES; HUMAN HEPATOCARCINOGENESIS; GLUTAMINE-SYNTHETASE; MACROREGENERATIVE NODULES; GLYPICAN-3; EXPRESSION; PRENEOPLASTIC LESIONS; MARKER; CELLS;
D O I
10.1055/s-0030-1247129
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Recently, an East-West consensus on the histopathologic criteria for the diagnosis of high-grade dysplastic nodules (HGDN) versus early hepatocellular carcinoma (HCC) was reached. Next to classical morphologic criteria such as nucleocytoplasmic ratio, thickness of cell plates, mitotic index, and architectural disturbance like acinar structures, one of the most relevant criteria to diagnose early HCC is stromal invasion. Because a structured basement membrane is lacking along the hepatocytes in the liver, invasion cannot be defined as tumor growth through the basement membrane as in other tissues. However, the number of portal tracts that are present in a nodule gradually decrease because the tumoral hepatocytes start to show a destructive invading growth pattern in the mesenchyma/stroma of these portal tracts. This feature of stromal invasion is however sometimes difficult to recognize in needle biopsies because included portal tracts can be absent. Therefore, other diagnostic criteria are necessary. Based on molecular profiling, several additional markers for early malignant HCC have been found recently. Glypican-3, heat shock protein 70, and glutamine synthetase have been already validated and can be used as a panel of stains to confirm the pathologist's histopathologic diagnosis and to solve difficult cases.
引用
收藏
页码:17 / 25
页数:9
相关论文
共 50 条
  • [41] Capitalising on improved rates of diagnosis of early hepatocellular carcinoma
    Rowe, Ian A.
    Sherman, Morris
    JOURNAL OF HEPATOLOGY, 2016, 64 (02) : 260 - 261
  • [42] EARLY DIAGNOSIS OF HEPATOCELLULAR-CARCINOMA THERAPEUTIC IMPLICATIONS
    BRUIX, J
    MEDICINA CLINICA, 1993, 100 (06): : 228 - 234
  • [43] Very Early Diagnosis of Hepatocellular Carcinoma: Serological Approaches
    Johnson, P. J.
    JOURNAL OF PATHOLOGY, 2019, 248 : S3 - S3
  • [44] Developing an electrochemical immunosensor for early diagnosis of hepatocellular carcinoma
    Al-Shami, Abdulrahman
    Oweis, Rami Joseph
    Al-Fandi, Mohamed Ghazi
    SENSOR REVIEW, 2021, 41 (02) : 125 - 134
  • [45] Present and future possibilities for early diagnosis of hepatocellular carcinoma
    Piotr Stefaniuk
    Janusz Cianciara
    Alicja Wiercinska-Drapalo
    World Journal of Gastroenterology, 2010, 16 (04) : 418 - 424
  • [46] HEPATOCELLULAR-CARCINOMA - SEARCH FOR STRATEGIES IN EARLY DIAGNOSIS
    FARINATI, F
    CHIARAMONTE, M
    RUGGE, M
    SALVAGNINI, M
    ZAGOLIN, M
    GUIDO, M
    NACCARATO, R
    PATHOPHYSIOLOGY OF THE LIVER, 1988, 786 : 217 - 226
  • [47] Early Diagnosis of Hepatocellular Carcinoma: It's Not a Matter of Opinion
    Caturelli, Eugenio
    Ghittoni, Giorgia
    HEPATOLOGY, 2012, 56 (02)
  • [48] Updates on early diagnosis and management of hepatocellular carcinoma in HBV
    Komolmit, P.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2012, 16 : E21 - E21
  • [49] ULTRASONOGRAPHIC SCREENING IN THE EARLY DIAGNOSIS OF HEPATOCELLULAR-CARCINOMA
    CEREZO, FJM
    PUIG, M
    NOGUERAS, AM
    TOMAS, A
    PAMPLONA, J
    BALANZO, J
    ENRIQUEZ, J
    VILARDELL, F
    GUARNER, C
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 1993, 84 (05) : 311 - 314
  • [50] Present and future possibilities for early diagnosis of hepatocellular carcinoma
    Stefaniuk, Piotr
    Cianciara, Janusz
    Wiercinska-Drapalo, Alicja
    WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (04) : 418 - 424